SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-326293
Filing Date
2018-11-14
Accepted
2018-11-14 09:02:56
Documents
32
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d613945d10q.htm 10-Q 212858
2 EX-31.1 d613945dex311.htm EX-31.1 6465
3 EX-31.2 d613945dex312.htm EX-31.2 6468
4 EX-32.1 d613945dex321.htm EX-32.1 3141
5 EX-32.2 d613945dex322.htm EX-32.2 2969
  Complete submission text file 0001193125-18-326293.txt   1520021

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hppi-20180930.xml EX-101.INS 190714
7 XBRL TAXONOMY EXTENSION SCHEMA hppi-20180930.xsd EX-101.SCH 22703
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20180930_cal.xml EX-101.CAL 22239
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20180930_def.xml EX-101.DEF 85954
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20180930_lab.xml EX-101.LAB 192788
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20180930_pre.xml EX-101.PRE 126770
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 181180619
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9